Preventing stroke recurrence with cilostazol for small vessel disease
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether cilostazol, a medication that helps keep blood flowing, can prevent another stroke and slow down disease progression in people who have had a recent stroke caused by small vessel disease. It aims to stop the brain damage from getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 80 years old.
- Had a stroke due to small blood vessel blockage within the last 6 months.
- Brain MRI shows moderate or severe white matter changes (Fazekas grade 2 or higher).
- Able to walk and care for yourself with little or no help (mRS score 0–2).
- No significant memory or thinking problems (Clinical Dementia Rating score less than 1).
- No recent or ongoing bleeding issues, heart failure, or need for blood thinners like warfarin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called cilostazol to see if it can help prevent a second stroke or mini-stroke. You may be a candidate if you have had a stroke or mini-stroke in the past 6 months and are already taking one blood thinner (aspirin or clopidogrel), but not both.
This trial tests if the drug cilostazol can prevent another stroke in people who have already had one. It is designed for patients in Africa and compares adding cilostazol to standard aspirin or clopidogrel therapy.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
Hear when a new Cerebral Small Vessel Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.